Statistics in Medicine

Article	Citations
	135
Skewness‐Corrected Confidence Intervals for Predictive Values in Enrichment Studies	119
	74
Tracking the transmission dynamics of COVID‐19 with a time‐varying coefficient state‐space model	63
Transportability of model‐based estimands in evidence synthesis	58
Data fusion for predicting long‐term program impacts	51
Sample size considerations for assessing treatment effect heterogeneity in randomized trials with heterogeneous intracluster correlations and variances	47
Modeling the multi‐state natural history of rare diseases with heterogeneous individual patient data: A simulation study	45
Evaluating joint confidence region of hypervolume under ROC manifold and generalized Youden index	44
Bayesian additive regression trees for multivariate skewed responses	42
Confidence Intervals for AUC and pAUC by Empirical Likelihood	41
BEATS: Bayesian hybrid design with flexible sample size adaptation for time‐to‐event endpoints	39
Bayesian Safety and Futility Monitoring in Phase II Trials Using One Utility‐Based Rule	35
The Whys, Whens, and Hows of Futility Monitoring	33
Multi‐Study Factor Regression Model: An Application in Nutritional Epidemiology	32
Issue Information	31
Issue Information	28
Issue Information	27
Correction to “A Comparison of Methods to Adjust Survival Curves for Confounders”	26
Bayesian Borrowing With Multiple Heterogeneous Historical Studies Using Order Restricted Normalized Power Prior	26
Dynamic Single‐Index Scalar‐On‐Function Model	26
The polytomous discrimination index for prediction involving multistate processes under intermittent observation	24
Cumulative Logit Ordinal Regression With Proportional Odds Under Nonignorable Missing Responses—Application to Phase III Trial	23
Semiparametric multivariate joint model for skewed‐longitudinal and survival data: A Bayesian approach	23
Flexible Empirical Bayesian Approaches to Pharmacovigilance for Simultaneous Signal Detection and Signal Strength Estimation in Spontaneous Reporting Systems Data	23

Classification of disease recurrence using transition likelihoods with expectation‐maximization algorithm	21
Optimal confidence intervals for the relative risk and odds ratio	21
Handling parametric assumptions in principal causal effect estimation using Gaussian mixtures	21
Synthesizing studies for comparing different treatment sequences in clinical trials	20
Leveraging External Aggregated Information for the Marginal Accelerated Failure Time Model	19
Bayesian mixture modelling with ranked set samples	19
Network and covariate adjusted response‐adaptive design for binary response	19
Real time monitoring and prediction of time to endpoint maturation in clinical trials	18
Handling Missing Outcome Data in Cluster Randomized Trials With Both Individual‐ and Cluster‐Level Dropout	18
	18
On the parameter estimation of Box‐Cox transformation cure model	18
Improving main analysis by borrowing information from auxiliary data	18
Accounting for Misclassification of Binary Outcomes in External Control Arm Studies for Unanchored Indirect Comparisons: Simulations and Applied Example	18
	17
	17
Robustness of κ‐type coefficients for clinical agreement	17
Balancing versus modelling in weighted analysis of non‐randomised studies with survival outcomes: A simulation study	17
Dose finding studies for therapies with late‐onset toxicities: A comparison study of designs	17
Regression Trees With Fused Leaves	16
Generalized additive models to analyze nonlinear trends in biomedical longitudinal data using R: Beyond repeated measures ANOVA and linear mixed models	16
Estimands for factorial trials	16
Non‐Parametric Estimation for Semi‐Competing Risks Data With Event Misascertainment	15
Relative sparsity for medical decision problems	15
A Hierarchical Bayesian Model for Estimating Age‐Specific COVID‐19 Infection Fatality Rates in Developing Countries	15
Issue Information	14
A two‐stage group‐sequential design for delayed treatment responses with the possibility of trial restart	14
A combined multilevel factor analysis and covariance regression model with mixed effects in the mean and variance structure	14
An inverse probability weighted regression method that accounts for right‐censoring for causal inference with multiple treatments and a binary outcome	14
A Novel Stratified Analysis Method for Testing and Estimating Overall Treatment Effects on Time‐To‐Event Outcomes Using Average Hazard With Survival Weight	14
Multiple multi‐sample testing under arbitrary covariance dependency	14
Kernel Cox partially linear regression: Building predictive models for cancer patients' survival	14
A Biomarker Signature‐Guided Clinical Trial Design for Precision Medicine	14
Adjusted Nelson–Aalen Estimators by Inverse Treatment Probability Weighting With an Estimated Propensity Score	14
Estimating contact network properties by integrating multiple data sources associated with infectious diseases	14
Multilevel joint model of longitudinal continuous and binary outcomes for hierarchically structured data	14
Instrumental variable analysis for cost outcome: Application to the effect of primary care visit on medical cost among low‐income adults	13
Distribution–free hyperrectangular tolerance regions for setting multivariate reference regions in laboratory medicine	13
Modeling variation in mixture effects over space with a Bayesian spatially varying mixture model	13
Adjusted closed‐form confidence interval formulas for network meta‐analysis with a small number of studies	13
Nonparametric empirical Bayes biomarker imputation and estimation	13
Sensitivity analysis of G‐estimators to invalid instrumental variables	13
Information‐incorporated sparse hierarchical cancer heterogeneity analysis	13
Modeling intra‐individual inter‐trial EEG response variability in autism	13
A Bayesian method to detect drug‐drug interaction using external information for spontaneous reporting system	12
Weighted McNemar's test for the comparison of two screening tests in the presence of verification bias	12
Asymptotic Confidence Interval, Sample Size Formulas and Comparison Test for the Agreement Intra‐Class Correlation Coefficient in Inter‐Rater Reliability Studies	12
Robust Estimation of Additive Shared‐Frailty Models for Recurrent Event Data With Dependent Censoring	12
A systematic review and evaluation of statistical methods for group variable selection	12
Multilevel Longitudinal Functional Principal Component Model	12
Model‐assisted analyses of longitudinal, ordinal outcomes with absorbing states	12

Instrumental variable model average with applications in Mendelian randomization	12
What's the Weight? Estimating Controlled Outcome Differences in Complex Surveys for Health Disparities Research	12
A shared‐parameter location‐scale mixed model to link the responsivity in self‐initiated event reports and the event‐contingent Ecological Momentary Assessments	12
Random Survival Forest With Multiple Imputation Analysis for Case‐Cohort and Generalized Case‐Cohort Studies	12
Optimal adaptive allocation using deep reinforcement learning in a dose‐response study	12
Finding the best subgroup with differential treatment effect with multiple outcomes	12
IDNetwork: A deep illness‐death network based on multi‐state event history process for disease prognostication	11
Natural Effects in the Presence of an Intermediate Confounder: Evaluation of Pragmatic Estimation Strategies With an Emphasis on the Relationship Between Natural and Interventional Effects	11
	11
Quantile partially linear additive model for data with dropouts and an application to modeling cognitive decline	11
Genetic Prediction Modeling in Large Cohort Studies via Boosting Targeted Loss Functions	11
Covariate adjustment in randomized clinical trials with missing covariate and outcome data	11
	11
Outlier Detection in Mendelian Randomization	11
Variability in Causal Effects and Noncompliance in a Multisite Trial: A Bivariate Hierarchical Generalized Random Coefficients Model for a Binary Outcome	11
	11
Standardization and other approaches to meta‐analyze differences in means	11
Frequentist Grouped Weighted Quantile Sum Regression for Correlated Chemical Mixtures	10
Issue Information	10
Handling missing within‐study correlations in the evaluation of surrogate endpoints	10
	10
Optimal weighted Bonferroni tests and their graphical extensions	10
Joint regression modelling of intensity and timing of accelerometer counts	10
BHAFT: Bayesian heredity‐constrained accelerated failure time models for detecting gene‐environment interactions in survival analysis	10
	10
Issue Information	10
Obituary: Anthony Leonard Johnson (1943‐2022)	10
Issue Information	10
Analysis of composite endpoints with component‐wise censoring in the presence of differential visit schedules	9
Distribution‐free model selection for longitudinal zero‐inflated count data with missing responses and covariates	9
Group sequential designs for clinical trials when the maximum sample size is uncertain	9
Flexible template matching for observational study design	9
An information‐theoretic approach for the assessment of a continuous outcome as a surrogate for a binary true endpoint based on causal inference: Application to vaccine evaluation	9
Combining information to estimate adherence in studies of pre‐exposure prophylaxis for HIV prevention: Application to HPTN 067	9
Q‐Learning in Dynamic Treatment Regimes With Misclassified Binary Outcome	9
Robust inference for causal mediation analysis of recurrent event data	9
Complex survival trial design by the product integration method	9
Structured time‐dependent inverse regression (STIR)	9
Correction to “Using principal stratification in analysis of clinical trials”	9
The impact of correlated exposures and missing data on multiple informant models used to identify critical exposure windows	9
Estimating mixture effects and cumulative spatial risk over time simultaneously using a Bayesian index low‐rank kriging multiple membership model	9
Choosing clinically interpretable summary measures and robust analytic procedures for quantifying the treatment difference in comparative clinical studies	9
Inverse probability of treatment weighting with generalized linear outcome models for doubly robust estimation	9
Local false discovery rate estimation with competition‐based procedures for variable selection	9
Propensity score analysis with local balance	9
	9
Understanding an impact of patient enrollment pattern on predictability of central (unstratified) randomization in a multi‐center clinical trial	9
Association analysis of self‐reported outcomes with a validated subset	9
Penalized smoothing splines resolve the curvature identifiability problem in age‐period‐cohort models with unequal intervals	8
	8
Statistical inference for time‐to‐event data in non‐randomized cohorts with selective attrition	8
Mixed‐type multivariate response regression with covariance estimation	8
Causal inference methods for vaccine sieve analysis with effect modification	8
Multi‐threshold proportional hazards model and subgroup identification	8
Designing individually randomized group treatment trials with repeated outcome measurements using generalized estimating equations	8
Bland–Altman Plot for Censored Variables	8
A Brief Introduction on Latent Variable Based Ordinal Regression Models With an Application to Survey Data	8
Subgroup Testing in the Change‐Plane Cox Model	8
Robust structured heterogeneity analysis approach for high‐dimensional data	8
Identification and robust estimation of swapped direct and indirect effects: Mediation analysis with unmeasured mediator‐outcome confounding and intermediate confounding	8
Split and combine simulation extrapolation algorithm to correct geocoding coarsening of built environment exposures	8
	8
Flexible propensity score estimation strategies for clustered data in observational studies	8
Improve the Precision of Area Under the Curve Estimation for Recurrent Events Through Covariate Adjustment	8
A non‐parametric Bayesian approach for adjusting partial compliance in sequential decision making	8
Peter Armitage speaking on the occasion of the 50th Anniversary of the M.Sc. in Medical Statistics, LSHTM (for the Symposium on April 11‐12, 2019)	8
	8
	8
A sequential, multiple assignment, randomized trial design with a tailoring function	8
	8
A nonparametric simultaneous confidence band for biomarker effect on the restricted mean survival time	8
Using fractional polynomials and restricted cubic splines to model non‐proportional hazards or time‐varying covariate effects in the Cox regression model	8
Transfer Learning for Error‐Contaminated Poisson Regression Models	8
Accounting for unequal cluster sizes in designing cluster randomized trials to detect treatment effect heterogeneity	8
Issue Information	7
Accommodating Spatial Heterogeneity in Geographically Weighted Regression with Group Penalty	7
A Simple Diagnostic for the Positivity Assumption for Continuous Exposures	7
A function‐based approach to model the measurement error in wearable devices	7
A distribution‐free procedure for testing versatile alternative in medical multisample comparison studies	7
Issue Information	7

Scaled average bioequivalence methods for highly variable drugs: Leveling‐off soft limits and the EMA's 2010 guideline (some ways to improve its type I error control)	7
Issue Information	7
A Comparison of Statistical Methods for Time‐To‐Event Analyses in Randomized Controlled Trials Under Non‐Proportional Hazards	7
Depthgram: Visualizing outliers in high‐dimensional functional data with application to fMRI data exploration	7
Power and Sample Size Calculations for Cluster Randomized Hybrid Type 2 Effectiveness‐Implementation Studies	7
Sample size determination for prediction models via learning‐type curves	7
On GEE for Mean‐Variance‐Correlation Models: Variance Estimation and Model Selection	7
An Alternative Measure for Quantifying the Heterogeneity in Meta‐Analysis	7
Weighted generalized estimating equations and unified estimation for longitudinal data with nonmonotone missing data patterns	7
Confidence intervals for odds ratio from multistage randomized phase II trials	7
Minimization in randomized clinical trials	7
Unlocking Cognitive Analysis Potential in Alzheimer's Disease Clinical Trials: Investigating Hierarchical Linear Models for Analyzing Novel Measurement Burst Design Data	7
A Bayesian Multivariate Model With Temporal Dependence on Random Partition of Areal Data for Mosquito‐Borne Diseases	7
Multilevel Regression and Poststratification Using Margins of Poststratifiers: Improving Inference for HIV Health Outcomes During the COVID‐19 Pandemic	7
MERIT: Controlling Monte‐Carlo error rate in large‐scale Monte‐Carlo hypothesis testing	7
A Varying‐Coefficient Additive Hazard Model for Recurrent Events Data	7
Profile‐likelihood Bayesian model averaging for two‐sample summary data Mendelian randomization in the presence of horizontal pleiotropy	7
Federated causal inference in heterogeneous observational data	7
A penalization approach to random‐effects meta‐analysis	7
Saddlepoint approximations to score test statistics in logistic regression for analyzing genome‐wide association studies	7
Issue Information	7
Statistical Inference for a Two‐Stage Adaptive Seamless Design Using Different Binary Endpoints	7
A Practical Framework to Design Immunization Studies Based on the Beta Distribution	7
Accounting for publication bias using a bivariate trim and fill meta‐analysis procedure	7
Deep Mixture of Linear Mixed Models for Complex Longitudinal Data	7
Issue Information	7
The Win Ratio Approach in Bayesian Monitoring for Two‐Arm Phase II Clinical Trial Designs With Multiple Time‐To‐Event Endpoints	7
A Unified Framework for Modeling Feedback and Endogeneity in Longitudinal Binary Outcomes Using Bayesian Methods	7
Confidence Intervals for Adaptive Trial Designs II: Case Study and Practical Guidance	7
Testing for the Functional Form of a Continuous Covariate in the Shared‐Parameter Joint Model	7
Ensemble of Sequential Learning Models With Distributed Data Centers and Its Applications	7
Matching‐Assisted Power Prior for Incorporating Real‐World Data in Randomized Clinical Trial Analysis	6
Exploiting relationship directionality to enhance statistical modeling of peer‐influence across social networks	6
	6
Fitting a stochastic model of intensive care occupancy to noisy hospitalization time series during the COVID‐19 pandemic	6
Reinforced Borrowing Framework: Leveraging Auxiliary Data for Individualized Inference	6
Fusing trial data for treatment comparisons: Single vs multi‐span bridging	6
A comparison of Bayesian information borrowing methods in basket trials and a novel proposal of modified exchangeability‐nonexchangeability method	6
Penalized maximum likelihood inference under the mixture cure model in sparse data	6
Parameter estimation and forecasting with quantified uncertainty for ordinary differential equation models using QuantDiffForecast: A MATLAB toolbox and tutorial	6
Low‐rank latent matrix‐factor prediction modeling for generalized high‐dimensional matrix‐variate regression	6
Bayesian Modeling of Cancer Outcomes Using Genetic Variables Assisted by Pathological Imaging Data	6
Blinded sample size re‐estimation for comparing over‐dispersed count data incorporating follow‐up lengths	6
Approximate likelihood‐based estimation method of multiple‐type pathogen interactions: An application to longitudinal pneumococcal carriage data	6
A Bayesian non‐stationary heteroskedastic time series model for multivariate critical care data	6
Gaussian variational approximate inference for joint models of longitudinal biomarkers and a survival outcome	6
Fitting additive risk models using auxiliary information	6
A unified Bayesian framework for bias adjustment in multiple comparisons from clinical trials	6
Subgroup analysis using Bernoulli‐gated hierarchical mixtures of experts models	6
Using temporal recalibration to improve the calibration of risk prediction models in competing risk settings when there are trends in survival over time	6
Using a mixed‐effect model with a parameter‐space of heterogenous dimension to evaluate whether accountable care organizations are associated with greater uniformity across constituent practices	6
A Note on the Sample Size Formula for a Win Ratio Endpoint	6
Bayesian predictive model averaging approach to joint longitudinal‐survival modeling: Application to an immuno‐oncology clinical trial	6
Trial emulation and survival analysis for disease incidence registers: A case study on the causal effect of pre‐emptive kidney transplantation	6
Properties of the full random‐effect modeling approach with missing covariate data	6
	6
Allocation in platform trials to maintain comparability across time and eligibility	6
Active‐Controlled Trial Design for HIV Prevention Trials With a Counterfactual Placebo	6
A Bayesian semi‐parametric scalar‐on‐function regression with measurement error using instrumental variables	6
Evaluating analytic models for individually randomized group treatment trials with complex clustering in nested and crossed designs	6
Two‐stage stratified designs with survival outcomes and adjustment for misclassification in predictive biomarkers	6
Tony Johnson—memories and a tribute	6
Robust analysis of cancer heterogeneity for high‐dimensional data	6
The Cox Model With Adaptive Fused Group Bridge Penalty to Incorporate Historical Data Into the Analysis of Clinical Trials With an Application to BMT CTN 1101	6
A classification for complex imbalanced data in disease screening and early diagnosis	6
Sensitivity Analysis for Effects of Multiple Exposures in the Presence of Unmeasured Confounding: Non‐Gaussian and Time‐to‐Event Outcomes	6
Multiple imputation approaches for handling incomplete three‐level data with time‐varying cluster‐memberships	6
Score Test for Functional Markov Process With Image Predictor	6
Fast estimation of mixed‐effects location‐scale regression models	6
Radiomics of PET Using Neural Networks for Prediction of Alzheimer's Disease Diagnosis	6
A proper statistical inference framework to compare clinical trial and real‐world progression‐free survival data	6
Assessing heterogeneity in surrogacy using censored data	6
A conditional autoregressive model for genetic association analysis accounting for genetic heterogeneity	6
	6
A comparison of different methods to adjust survival curves for confounders	6
Multivariate functional mixed model with MRI data: An application to Alzheimer's disease	6
Analysis of Cohort Stepped Wedge Cluster‐Randomized Trials With Nonignorable Dropout via Joint Modeling	6
Nonparametric estimation of marked survival data in the presence of dependent censoring	5
Integrating Complex Selection Rules Into the Latent Overlapping Group Lasso for the Construction of Coherent Prediction Models	5
Issue Information	5
Confidence Intervals and Sample Size for the ICC in Two‐Way ANOVA Models	5
A Bayesian phase I/II platform design for co‐developing drug combination therapies for multiple indications	5
New late‐emphasis and combination tests based on infimum and supremum logrank statistics with application in oncology trials	5
Two‐stage targeted maximum likelihood estimation for mixed aggregate and individual participant data analysis with an application to multidrug resistant tuberculosis	5
Issue Information	5
Issue Information	5
Overall assessment for selected markers from high‐throughput data	5
Bayesian spatial models for voxel‐wise prostate cancer classification using multi‐parametric magnetic resonance imaging data	5
Individualized empirical null estimation for exact tests of healthcare quality	5
Bayesian federated inference for estimating statistical models based on non‐shared multicenter data sets	5
Issue Information	5
Event‐specific win ratios for inference with terminal and non‐terminal events	5
Likelihood ratio combination of multiple biomarkers via smoothing spline estimated densities	5
Testing a global null hypothesis using ensemble machine learning methods	5
Approximate Bayesian computation for the natural history of breast cancer, with application to data from a Milan cohort study	5